05.26.17
Recipharm has invested in its UK and Ireland presence with the appointment of Shabbir Mostafa to its business management team. He will join the Sweden-headquartered contract development and manufacturing organization (CDMO) as director, business management UK and Ireland with responsibility for supporting customers in those regions and driving sales of Recipharm’s manufacturing services.
“The UK and Ireland continues to be an important market for Recipharm as we expand our localized presence throughout Europe,” said Kenth Berg, vice president business management, Recipharm. “Our vision is to be recognized as the best-in-class provider of contract development and manufacturing solutions to the pharmaceutical industry and in order to achieve this, we are focused on attracting and recruiting excellent people.”
With a PhD in pharmaceutical sciences, Mr. Mostafa joins Recipharm from Aesica Pharmaceuticals where he was the business development director with responsibility for global formulation development services and the commercial finished dose business in the UK and Ireland. During his 15-year career, he has also held positions at PCI Pharma Services, Gattefossé, Patheon and IVAX Pharmaceuticals.
“The UK and Ireland continues to be an important market for Recipharm as we expand our localized presence throughout Europe,” said Kenth Berg, vice president business management, Recipharm. “Our vision is to be recognized as the best-in-class provider of contract development and manufacturing solutions to the pharmaceutical industry and in order to achieve this, we are focused on attracting and recruiting excellent people.”
With a PhD in pharmaceutical sciences, Mr. Mostafa joins Recipharm from Aesica Pharmaceuticals where he was the business development director with responsibility for global formulation development services and the commercial finished dose business in the UK and Ireland. During his 15-year career, he has also held positions at PCI Pharma Services, Gattefossé, Patheon and IVAX Pharmaceuticals.
